# Decongestion Guided By VExUS Score Or Lung Ultrasound For Renal Recovery In Patients With Cardiorenal Syndrome Type -1

> **NCT06786728** · NA · ENROLLING_BY_INVITATION · sponsor: **Benha University** · enrollment: 146 (estimated)

## Conditions studied

- Cardiorenal Syndrome Type 1

## Interventions

- **DRUG:** frusemide

## Key facts

- **NCT ID:** NCT06786728
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-08-10
- **Primary completion:** 2025-07
- **Final completion:** 2025-08
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06786728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06786728, "Decongestion Guided By VExUS Score Or Lung Ultrasound For Renal Recovery In Patients With Cardiorenal Syndrome Type -1". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06786728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*